Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates
Published: July 02, 2012
- Cardiovascular disease is a major cause of morbidity and mortality for those with end-stage non-cardiac organ failure both before and after transplantation.
- The unique characteristics of end-organ failure transplant candidates require careful consideration during cardiac evaluation.
- This paper addresses gaps in existing guidelines for consideration during cardiac disease evaluation in kidney and liver transplant candidates.
Supporting Materials
- Commentary: Bringing Harmony to the Cacophony of Cardiovascular Disease Assessment for Potential Kidney Liver Transplant Candidates. A Case for Assimilating the New AHA/ACCF Guidelines by Christopher deFilippi, M.D.
- Top Things to Know: Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates